Boaz Amichai

Summary

Country: Israel

Publications

  1. ncbi request reprint Onychomycosis: rationalization of topical treatment
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Isr Med Assoc J 10:415-6. 2008
  2. doi request reprint Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study
    B Amichai
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Br J Dermatol 162:46-50. 2010
  3. doi request reprint Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails
    Boaz Amichai
    Huzot Clinic, Clalit Health Services, Ashkelon, Israel
    Mycopathologia 169:343-9. 2010
  4. ncbi request reprint Novel mutations in two families with Darier's disease
    B Amichai
    Department of Dermatology, Huzot Clinic of Clalit Health Services, Ashkelon, Israel
    Int J Dermatol 46:64-7. 2007
  5. ncbi request reprint Cutaneous hyperpigmentation during therapy with hydroxychloroquine
    Boaz Amichai
    Huzot Clinic, Clalit Health Services, Ashkelon, Israel
    J Clin Rheumatol 13:113. 2007
  6. doi request reprint A rationale for systemic treatment in onychomycosis with negative results on fungal examination
    B Amichai
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Clin Exp Dermatol 36:724-7. 2011
  7. doi request reprint A randomized, double-blind, placebo-controlled study to evaluate the efficacy in AD of liquid soap containing 12% ammonium lactate + 20% urea
    B Amichai
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Clin Exp Dermatol 34:e602-4. 2009
  8. doi request reprint Comparative study of nail sampling techniques in onychomycosis
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    J Dermatol 36:410-4. 2009
  9. doi request reprint Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    J Dermatol 37:137-9. 2010
  10. ncbi request reprint Onychomycosis in psoriatic patients - rationalization of systemic treatment
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Mycoses 53:340-3. 2010

Collaborators

  • Avner Shemer
  • Alon Scope
  • Anna Lyakhovitsky
  • Marcelo H Grunwald
  • A Barzilai
  • A Lyakhovitsky
  • Henri Trau
  • Jacob Rimer
  • Sharon Baum
  • S Baum
  • D Shpiro
  • M Solomon
  • R Heyman
  • H Trau
  • Andera Gat
  • Dan Ben Amitai

Detail Information

Publications22

  1. ncbi request reprint Onychomycosis: rationalization of topical treatment
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Isr Med Assoc J 10:415-6. 2008
    ..Fungal infection of the nail affects millions of people worldwide and has an estimated prevalence of more than 10% of the general population...
  2. doi request reprint Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study
    B Amichai
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Br J Dermatol 162:46-50. 2010
    ..Conclusions The delivery of terbinafine under an electrical current of 100 microA cm(-2) appears to be efficacious and safe and is well tolerated for the treatment of nail onychomycosis...
  3. doi request reprint Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails
    Boaz Amichai
    Huzot Clinic, Clalit Health Services, Ashkelon, Israel
    Mycopathologia 169:343-9. 2010
    ..Successful treatment of deep-seated nail infections remains elusive as the delivery of efficacious levels of antifungal drug to the site of action is very difficult...
  4. ncbi request reprint Novel mutations in two families with Darier's disease
    B Amichai
    Department of Dermatology, Huzot Clinic of Clalit Health Services, Ashkelon, Israel
    Int J Dermatol 46:64-7. 2007
    ..Deleterious mutations in the gene ATP2A2 which encodes SERCA2, a calcium pump of the sarco/endoplasmic reticulum underlie the disease...
  5. ncbi request reprint Cutaneous hyperpigmentation during therapy with hydroxychloroquine
    Boaz Amichai
    Huzot Clinic, Clalit Health Services, Ashkelon, Israel
    J Clin Rheumatol 13:113. 2007
  6. doi request reprint A rationale for systemic treatment in onychomycosis with negative results on fungal examination
    B Amichai
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Clin Exp Dermatol 36:724-7. 2011
    ..Laboratory confirmation of fungal infection is currently accepted as a requirement before initiation of antifungal treatment in clinical practice...
  7. doi request reprint A randomized, double-blind, placebo-controlled study to evaluate the efficacy in AD of liquid soap containing 12% ammonium lactate + 20% urea
    B Amichai
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Clin Exp Dermatol 34:e602-4. 2009
    ..001) in the study group compared with the control group. The liquid soap was found to be effective in patients with AD, as use of this soap in patients with stable mild to moderate AD improved the parameters studied...
  8. doi request reprint Comparative study of nail sampling techniques in onychomycosis
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    J Dermatol 36:410-4. 2009
    ..With each technique we found that the culture sensitivity improved as the location of the sample was more proximal. More types of pathogens were detected in samples taken by both methods from proximal parts of the affected nails...
  9. doi request reprint Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    J Dermatol 37:137-9. 2010
    ..No adverse effects were noted throughout the treatment period. Ciclopirox nail lacquer seems to be slightly more effective than other topical modalities and could be used in patients who cannot or do not want systemic treatment...
  10. ncbi request reprint Onychomycosis in psoriatic patients - rationalization of systemic treatment
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Mycoses 53:340-3. 2010
    ..Considering the low response to onychomycosis systemic therapy in psoriatic patients and the potential side-effects of the treatment, the rationality of this treatment is questionable...
  11. ncbi request reprint Nail sampling in onychomycosis: comparative study of curettage from three sites of the infected nail
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    J Dtsch Dermatol Ges 5:1108-11. 2007
    ..The purpose of this study was to compare results of curettage technique of nail sampling in the diagnosis of onychomycosis from three different sites of the affected nail to establish the best location of sampling...
  12. ncbi request reprint Onychomycosis: a simpler in-office technique for sampling specimens
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    J Fam Pract 61:552-4. 2012
    ..In onychomycosis, proper specimen collection is essential for an accurate diagnosis and initiation of appropriate therapy. Several techniques and locations have been suggested for specimen collection...
  13. ncbi request reprint Treatment of moderate to severe facial seborrheic dermatitis with itraconazole: an open non-comparative study
    Avner Shemer
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Isr Med Assoc J 10:417-8. 2008
    ..Seborrheic dermatitis is a common chronic disease. Malassezia yeasts have been implicated in the pathogenesis of this disease. Antifungal agents are known to be effective in the treatment of Malassezia yeast infections...
  14. ncbi request reprint Pseudomelanoma after Solcoderm treatment
    Marcelo H Grunwald
    Department of Dermatology, Soroka University Medical Center, Ben Gurion University of the Negev, Beer Sheva, Israel
    Melanoma Res 16:459-60. 2006
    ..Appearance of pseudomelanoma after Solcoderm treatment stressed the controversy of the use of Solcoderm in pigmentary lesions, and that surgical removal is preferred in cases of pigmented nevi...
  15. doi request reprint Molecular analysis of Malassezia species isolated from Israeli patients with pityriasis versicolor
    Anna Lyakhovitsky
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel
    Int J Dermatol 52:231-3. 2013
    ..The clinical significance of each of these species is not fully understood. M. furfur has long been identified as the causative agent of PV. Several recent studies suggest that M. globosa is most frequently associated with PV...
  16. doi request reprint The effect of domestic laundry processes on fungal contamination of socks
    Boaz Amichai
    Department of Dermatology, Meir Medical Center, Kfar Saba, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Int J Dermatol 52:1392-4. 2013
    ..Contravening current trends for energy saving and environmental protection, laundering at low temperatures is not effective in eradicating fungal pathogens, which requires high-temperature laundering at 60 °C...
  17. doi request reprint Treatment of tinea capitis - griseofulvin versus fluconazole - a comparative study
    Avner Shemer
    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    J Dtsch Dermatol Ges 11:737-41, 737-42. 2013
    ..To compare the efficacy and safety of fluconazole and griseofulvin in the treatment of tinea capitis...
  18. ncbi request reprint Low-dose isotretinoin in the treatment of acne vulgaris
    Boaz Amichai
    Huzot Clinic of Clalit Health Services, Ashkelon, Israel
    J Am Acad Dermatol 54:644-6. 2006
    ..The efficacy of isotretinoin at 0.5 to 1.0 mg/kg per day in the treatment of acne is well established and considered safe, although it is sometimes not easily tolerated because of its cutaneous side effects...
  19. ncbi request reprint Efficacy of a mucoadhesive patch compared with an oral solution for treatment of aphthous stomatitis
    Avner Shemer
    Department of Dermatology, C Sheba Medical Center, Ramat Gan, Israel
    Drugs R D 9:29-35. 2008
    ..The purpose of this study was to evaluate the efficacy and tolerability of a mucoadhesive patch compared with a pain-relieving oral solution for the treatment of aphthous stomatitis...
  20. doi request reprint The impact of stratifying initial dose of corticosteroids by severity of pemphigus vulgaris on long-term disease severity
    Anna Lyakhovitsky
    Department of Dermatology, Sheba Medical Center, Tel Hashomer, Israel Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
    Int J Dermatol 50:1014-9. 2011
    ..To this end, high-dose systemic corticosteroids have been advocated as first-line treatment for patients with PV to achieve disease control...
  21. doi request reprint Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults
    A Lyakhovitsky
    Sheba Medical Center Dermatology Department, Tel Hashomer, Ramat Gan, Israel
    J Eur Acad Dermatol Venereol 24:43-9. 2010
    ..This study assessed the efficacy and safety of treatment with low weekly doses of methotrexate for moderate-to-severe AD in adults...
  22. ncbi request reprint Macrolactam immunomodulators (tacrolimus and pimecrolimus): new horizons in the topical treatment of inflammatory skin diseases
    Marcelo H Grunwald
    Department of Dermatology, Soroka Medical Center, Ben Gurion University, Beer Sheva, Israel
    J Dermatol 31:592-602. 2004
    ..In this article, we review the pharmacologic properties of the drugs, their side effects, and their clinical uses...